Latest news with #ECG
Associated Press
a day ago
- Business
- Associated Press
IBN Coverage: HeartBeam (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. LOS ANGELES, CA - June 20, 2025 ( NEWMEDIAWIRE ) - HeartBeam (NASDAQ: BEAT) announced it has received FDA 510(k) clearance for its flagship ECG system, a first-of-its-kind, credit card-sized, cable-free device designed to deliver high-fidelity, three-directional cardiac recordings for arrhythmia evaluation. The clearance marks a major regulatory milestone and accelerates HeartBeam's plans to improve access to timely, remote cardiac care. When symptoms arise, patients use the app-guided system to record a 30-second ECG, which is automatically uploaded to the cloud for physician review in the context of medical history. The company will soon launch an Early Access Program to engage early adopters and providers ahead of broader commercialization. This foundational clearance also sets the stage for future advancements, including 12-lead ECG synthesis, AI-based arrhythmia detection, and remote heart attack risk scoring. HeartBeam's long-term vision is to revolutionize cardiac care by enabling continuous, predictive insights outside traditional clinical settings. To view the full press release, visit About HeartBeam Inc. HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The company is creating the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care - all outside of a medical facility, thus redefining the future of cardiac health management. The company holds 13 U.S. and 4 international-issued patents related to technology enablement. For more information, visit NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: The latest news and updates relating to BEAT are available in the company's newsroom at Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading 'Risk Factors' discussed under the caption 'Item 1A. Risk Factors' in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption 'Item 1A. Risk Factors' in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law. About IBN IBN is a cutting-edge communications and digital engagement platform providing tailored Platform Solutions for select private and public companies. Over the course of 19+ years, IBN has introduced over 70 investor facing brands to the investment public and amassed a collective audience of millions of social media followers. These distinctive investor brands amplify recognition and reach as well as help fulfill the unique needs of our rapidly growing and diverse base of client-partners. IBN will continue to expand our branded network of influential properties as well as leverage the energy and experience of our team of professionals to best serve our clients. IBN's Platform Solutions provide access to: (1) our Dynamic Brand Portfolio (DBP) through 70+ investor facing brands; (2) article and editorial syndication to 5,000+ news outlets; (3) full-scale distribution to a growing Social Media Network (SMN) ; (4) a network of wire solutions via InvestorWire to effectively reach target markets and demographics; (5) Press Release Enhancement to ensure accuracy and impact; (6) a full array of corporate communications solutions; and (7) total news coverage solutions. For more information, please visit Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: Media Contact IBN Los Angeles, California 310.299.1717 Office [email protected]
Medscape
a day ago
- Health
- Medscape
ECG Challenge: On-Again, Off-Again Lightheadedness
A 72-year-old man with a history of coronary artery disease treated medically presents to his primary care provider with complaints of palpitations and occasional episodes of lightheadedness. He has had episodic lightheadedness with presyncope, but no syncope, over the past 2 months. The episodes have become more frequent over the past 2 weeks. While an ECG is obtained, he complaints of lightheadedness. Figure 1. Courtesy of Philip J. Podrid, MD. The correct diagnosis is tachycardia-bradycardia (sick sinus syndrome; Figure 2). Figure 2. Courtesy of Philip J. Podrid, MD. Discussion The initial four RR intervals are irregularly irregular. No organized P waves are seen, but there are irregular undulations of the baseline (^). The QRS complexes have a normal duration (0.08 sec) and morphology. Therefore, the initial rhythm is atrial fibrillation. The atrial fibrillation abruptly terminates after the first four QRS complexes, followed by a QRS complex (*) that has the same duration and morphology as the first four. However, no P wave occurs before this QRS complex. Therefore, this is a junctional escape complex. This is followed by three additional junctional QRS complexes (v). The RR intervals are shortening (rate faster) because the junctional complexes are from an ectopic focus which manifests a change in its rate. The last two QRS complexes have the same duration and morphology. However, they are preceded by a P wave (+) with a stable PR interval (0.16 sec). Thus, these are sinus complexes. The QT/QTc intervals are normal (320/390 msec). After the termination of the atrial fibrillation there is a delay of 8 seconds before sinus rhythm is restored. This represents a tachycardia-bradycardia (tachy-brady) syndrome, which is a common manifestation of sick sinus syndrome. Philip Podrid, MD, is an electrophysiologist, a professor of medicine and pharmacology at Boston University School of Medicine, and a lecturer in medicine at Harvard Medical School. Although retired from clinical practice, he continues to teach clinical cardiology and especially ECGs to medical students, house staff, and cardiology fellows at many major teaching hospitals in Massachusetts. In his limited free time he enjoys photography, music, and reading.
Associated Press
4 days ago
- Business
- Associated Press
IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. LOS ANGELES, CA - June 17, 2025 ( NEWMEDIAWIRE ) - HeartBeam (NASDAQ: BEAT) is a medical technology company developing a groundbreaking solution for at-home detection and monitoring of cardiac conditions. The company is creating the first ever cable-free synthesized 12-lead ECG platform designed to give patients the ability to record their symptoms the moment they occur, wherever they are. By providing synthesized, 12-lead ECG data, physicians can quickly assess the symptoms and ensure patients get the care they need in a timely manner. It also eliminates the need for wires, complex setup, or clinical staff, thus allowing synthesized 12-lead ECG signals to be accessible outside of a medical setting. HeartBeam's vision is to redefine cardiac care by enabling early detection, proactive monitoring, and informed clinical decisions outside the confines of a traditional medical setting. Its patented approach not only delivers similar, but not identical, accuracy of conventional 12-lead ECGs for arrhythmia detection… Read More NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: The latest news and updates relating to BEAT are available in the company's newsroom at Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading 'Risk Factors' discussed under the caption 'Item 1A. Risk Factors' in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption 'Item 1A. Risk Factors' in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law. About IBN IBN is a cutting-edge communications and digital engagement platform providing tailored Platform Solutions for select private and public companies. Over the course of 19+ years, IBN has introduced over 70 investor facing brands to the investment public and amassed a collective audience of millions of social media followers. These distinctive investor brands amplify recognition and reach as well as help fulfill the unique needs of our rapidly growing and diverse base of client-partners. IBN will continue to expand our branded network of influential properties as well as leverage the energy and experience of our team of professionals to best serve our clients. IBN's Platform Solutions provide access to: (1) our Dynamic Brand Portfolio (DBP) through 70+ investor facing brands; (2) article and editorial syndication to 5,000+ news outlets; (3) full-scale distribution to a growing Social Media Network (SMN) ; (4) a network of wire solutions via InvestorWire to effectively reach target markets and demographics; (5) Press Release Enhancement to ensure accuracy and impact; (6) a full array of corporate communications solutions; and (7) total news coverage solutions. For more information, please visit Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: Media Contact IBN Los Angeles, California 310.299.1717 Office [email protected]
Daily Mirror
03-06-2025
- Health
- Daily Mirror
UFC fighter who withdrew at last minute breaks silence after rival's dig
Maycee Barber has hit back at Erin Blanchfield's 'unprofessional' jibe after she was forced to pull out of their UFC Fight Night main event due to a seizure UFC sensation Maycee Barber has fiercely responded to Erin Blanchfield's jibe that her life is 'a mess' following a seizure that forced her out of their bout. The 27-year-old was set to headline UFC Fight Night at the UFC Apex against Blanchfield on Saturday evening. However, in a shocking turn of events, the flyweight clash was scrapped just before their entrance due to Barber suffering a seizure backstage. Blanchfield didn't hold back in criticising her opponent after the fight was called off, branding Barber 'unprofessional' and dismissing any possibility of rescheduling their match-up. As Blanchfield's scathing remarks went viral online, it did not take long for her rival to issue a response. Barber, who had to pull out of the fight on medical grounds, stood by her professionalism. "Not what I had planned for a Sunday post. Thank you to everyone for the prayers and support," she said. "I owe an apology to UFC, [UFC matchmaker] Mick Maynard, Dana White, [UFC matchmaker] Sean Shelby and Erin Blanchfield. "P.S: My life is not messy; this is just a bad hand. We will get to the bottom of it all and be back." The fighter also shared images on social media showing her connected to ECG leads, as well as a snapshot from her hospital bed, underlining the seriousness of her condition. Following her social media update, it was evident that she wasn't fit to fight in Saturday's main event. Prior to the contest, Barber had a mishap at the weigh-in, clocking in at 126.5lbs. The top contender aimed to continue her impressive spell in the cage, bouncing back from consecutive losses to Roxanne Modafferi and Alexa Grasso in 2020 and 2021 with a six-fight winning streak, claiming victories over rivals such as Jessica Eye, Amanda Ribas, and Katlyn Cerminara. Despite brutally criticising her rival, Blanchfield has recently changed course on her scathing remarks towards Barber. In an appearance on The Ariel Helwani Show, Blanchfield clarified her harsh comments after Barber's medical issues surfaced following Saturday night's fight card. 'She can't control medical issues that she's having, so that's not unprofessional. I meant more the weight miss on Friday and the way she approached it,' Blanchfield said. 'I believe she was offered more time to cut weight and didn't, missed weight and then still was acting the way she was at the weigh-ins. So that's more what I meant about being unprofessional…[being unreliable] I still stand by, she pulled out of the first [fight] and now this one. 'I know she has issues, but if she does have those severe medical issues, that's why I wouldn't want to be matched up with her again,' Blanchfield continued. 'I was caught up in the moment myself, she probably does have some issues…and she probably should've pulled out sooner so that I would've had another opponent. Not being honest about her condition wasn't the right thing to do.'
Time of India
01-06-2025
- Health
- Time of India
AIIMS-P to use AI-powered diagnostic equipment to improve patient care
Patna: All India Institute of Medical Sciences (AIIMS), Patna, has entered into a partnership with the e-health section of the ministry of health and family welfare to develop artificial intelligence (AI) powered solutions. It has recently also procured several AI-enabled medical devices to enhance patient treatment. Head of cardiothoracic surgery department at AIIMS-Patna, Dr Sanjiv Kumar, said that with the AI revolutionising healthcare, education, and research on a large scale, it has become crucial to build a strong foundational understanding of AI principles and applications now a days. "AI algorithms can detect maladies like cancer, heart disease, and neurological problems from medical images such as X-rays, MRIs, and CT scans. AI helps doctors determine patterns that human doctors may miss, thus improving their accuracy in diagnosing patients. Even a beginner can interpret an ECG properly with the AI-driven instrument," he said. Dr Kumar further pointed out that orthopaedic department of the AIIMS-Patna has started robotic surgery for the treatment of its patients with higher accuracy. In fact, AI has revolutionised the health care system in modern times with accurate data analysis and predictive health care, he added. Recently, the state health department has decided to launch an intensive screening of TB patients by using the technology of AI. Teams from the health department would move from village to village along with hand-held X-ray machines and AI-controlled mobile kits to identify the TB-affected people. Health department sources said that at present there are nearly two lakh TB patients in the state and more than 10,000 people affected by this disease have died during the last two years (2022-23 and 2023-24). Pramod Kumar Singh, director-in-chief (disease control) of state health department, said that the proposed screening would reveal the exact number of people suffering from TB. "AI will not only help immediate detection of TB patients with the help of X-ray and data analytics but also suggest the protocol of treatment of patients on the basis of their test reports. The department hopes that the screening will be completed soon so that proper treatment of the patients may be started at the earliest," he said. Dr Satish Kumar of Nalanda Medical College and Hospital (NMCH) said that equipment based on AI technology must be procured at all the health centres of the state with a view to ensuring early diagnosis and proper treatment of the patients. These machines would facilitate in reducing unwarranted rush of patients at the hospitals by curtailing the time of treatment, he said.
